AstraZeneca's combo lung disease therapy fails to win FDA approval
AstraZeneca's combo lung disease therapy fails to win FDA approval
Reuters: Health
The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combination therapy to treat smoker's lung, the drugmaker said on Tuesday.
No comments:
Post a Comment